Carlos C. Goller

  • Home
  • Author: Carlos C. Goller
  • Page 66

A Bed File to Create a Molecular Diagnostic Panel for Germline Cancer Predisposition

Tonight I continued watching the London Calling 2023 targeted sequencing showcase. In the four-minute recording entitled “The potential use of nanopore sequencing for molecular diagnosis of germline cancer predisposition,” Romain Boidot from the Centre Georges-François Leclerc in France spoke about their use of Oxford Nanopore Technologies (ONT) for molecular diagnosis and sequencing. Their current analysis […]
Read more

Clinicians and Bioinformaticians Using Nanopore for Diagnostics

Tonight I watched the London Calling 2023 panel “The future of clinical genomics.” Four panelists were asked several questions. The first was about the role of bioinformaticians in clinical work. One panelist spoke about how clinicians work on the automation and presenting the data. The exchange with bioinformaticians has helped the clinicians make the most […]
Read more

aPOG and Long-read Sequencing

Janessa Laskin from Canada’s Michael Smith Genome Sciences Centre at BC Cancer presented at London Calling 2023 on the “Potential use of nanopore sequencing in clinical cancer genomics.” Laskin is a clinician and medical oncologist. They spoke about the uncertainty of what treatments to select for patients and the idea of personalized medicine. Laskin explained […]
Read more

Liquid Biopsies for Longitudinal Non-invasive Cancer Monitoring

Tonight we started our first P2 run with two PromethION flow cells. I also continued watching the London Calling 2023 Showcase Stage on liquid biopsy. I watched them out of order! Today I watched Billy Lau from Stanford University School of Medicine do a quick presentation titled “Nanopore sequencing of cell-free DNA for methylation-based breast […]
Read more

Better Libraries and Improved Sequencing for Liquid Biopsy Samples

I continued watching the London Calling 2023 Showcase Stage sessions on liquid biopsies today. I watched the question and answer session. Panelists spoke about using amplicon panels and the Flongle. One panelist uses amplicon sequencing with Nanopore devices because they are able to go from sample to results in under eight hours. Another panelist answered […]
Read more

Multi-modal Liquid Biopsy Analysis in Children with Cancer

Tonight I watched the London Calling 2023 session entitled “The potential application of nanopore sequencing for liquid biopsy analysis in children with cancer.” The second speaker was Carolin Sauer, a public research fellow at EMBL-EBI in the UK. Sauer focused on pediatric cancers and noted that they are the leading cause of death in the […]
Read more

Sequencing Improvements for Diagnosis of Acutely Unwell Children in the UK

Emma Baple from the Royal Devon University Healthcare NHS Foundation Trust & the University of Exeter spoke at London Calling 2023 about “Empowering NHS rapid diagnostic testing with long-read sequencing.” They explained how rapid genetic tests for acutely ill children with rare diseases is critical, and they shared some intriguing statistics about the prevalence of […]
Read more

Basecamp Research Expeditions to Identify Novel Proteins

The London Calling 2023 showcase stage on conservation included a four-minute recorded session that I watched tonight. Phoebe Oldach from Basecamp Research spoke about “Building a comprehensive knowledge graph of novel proteins with long-read metagenomic sequencing and global partnerships.” They began by describing the field of identifying new proteins. Oldach explained that there is a […]
Read more
Press ESC key to close search